FDA Investigator Virginia Carroll, PhD
Virginia Carroll, PhD has conducted inspections on 5 sites in 4 countries as of 11 Jul 2022. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
11 Jul 2022
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Korea (Republic of),
United States of America,
Germany,
Japan
FDA Investigators that have inspected at least one site in common with Virginia Carroll, PhD:
Alicia M Mozzachio,
Amir Alavi,
Ashley N Queen, PhD,
Bruce H Mccullough,
Carla J Lundi,
Carrie A Hughes,
Caryn M Mcnab,
Cassandra L Abellard,
Cathleen A Carr Sharpe,
Christina Capacci Daniel, PhD,
Christopher R Czajka,
David G Whitman,
Deborah Schmiel, PhD,
Dennis Cantellops Paite,
Diane L Raccasi,
Dogbeda F Mackenzie,
Dr. Ralph M Bernstein, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Emilie E Kahn,
Esther C Broner, PhD,
Francis A Guidry,
Grace Deneke,
Helen B Ricalde,
Hyung Yul Lee,
Jacek Cieslak, PhD,
James L Dunnie, Jr,
Jeffrey P Raimondi,
Jennifer M Gogley,
Joan A Loreng,
Joao Pedras Vasconcelos, PhD,,
Joey V Quitania,
Katherine E Jacobitz,
Kumar G Janoria,
Lata C Mathew, PhD,
Laurel A Beer,
Laurimer Kuilan Torres,
LCDR Chad N Thompson,
Lestine C Webb,
Linda Thai,
Lucila B Nwatu,
Luis Mburgos Medero,
Madushini Dharmasena, PhD,
Marcellinus D Dordunoo,
Maria Gutierrez Lugo, PhD,
Maria Joselopez Barragan, PhD,
Marion Michaelis,
Matthew B Casale,
Melanie W Pishnery,
Michael A Charles,
Michael Shanks, MS,
Michael T Cyrus,
Monica Markovski, PhD,
Nayan J Patel,
Nicholas A Violand,
Omotunde O Osunsanmi,
Patricia F Hughes, PhD,
Patrick J Lynch,
Phillip Angart, PhD,
Prabhu P Raju,
Rebecca K Olin,
Reyes Candau Chacon, PhD,
Riley C Myers, PhD,
Roger F Zabinski,
Samantha J Bradley,
Santiago Gallardo Johnson,
Sarah Arden,
Sarah Johnson, PhD,
Sarah Kennett, PhD,
Stephen R Souza,
Steven Fong, MS, PhD,
Susan M Jackson,
Susan T Hadman,
Taichun Qin, PhD,
Thuy T Nguyen, LCDR,
Virgilio F Pacio, CSO,
Wayne E Seifert,
Xiaohui Shen,
Yi Wang, PhD,
Yun Wu, PhD,
Zachary A Bogorad,
Zhong Li, PhD
Virginia Carroll, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| December, 2019 | FDA 483 | Ajinomoto Althea, Inc. - Form 483, 2019-12-20 |
| May, 2018 | FDA 483 | Samsung Biologics Co., Ltd. - Form 483, 2018-05-11 |
| July, 2022 | EIR | Revance Therapeutics, Inc. - EIR, 2022-07-15 |
| July, 2022 | FDA 483 | Revance Therapeutics, Inc. - Form 483, 2022-07-15 |
| February, 2020 | FDA 483 | TERUMO YAMAGUCHI CORPORATION - Form 483, 2020-02-21 |
| December, 2019 | FDA 483 Response | Ajinomoto Althea, Inc. - Form 483R, 2019-12-20 |
| December, 2019 | EIR | Ajinomoto Althea, Inc. - EIR, 2019-12-20 |
| May, 2018 | EIR | Samsung Biologics Co., Ltd. - EIR, 2018-05-11 |
| November, 2019 | FDA 483 | Baxter Oncology GmbH - Form 483, 2019-11-05 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more